All In MedTech

FDA Clearance Tracker · P990028-S001

FOCALSEAL-L SYNTHETIC ABLSORBABLE SEALANT

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 20, 2001 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 20, 2001

Approved

Time to decision

266 days

Received Jul 28, 2000. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class II

The decision

FDA number
P990028-S001
Device name
FOCALSEAL-L SYNTHETIC ABLSORBABLE SEALANT
Applicant
Genzyme Corp.
Applicant location
Cambridge, MA
Received
Jul 28, 2000
Decided
Apr 20, 2001
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Postapproval Study Protocol
Original approval
P990028

Device type

Device class
Class II
Regulation
21 CFR 878.3300

Every decision under product code FTL

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE POST APPROVAL STUDY PROTOCOL PMS-0001-0.

Source documents

Other decisions for Genzyme Corp.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.